Clinical Trials Directory

Trials / Completed

CompletedNCT07333833

Development and Validation of an Early Prediction Model for Severe Mycoplasma Pneumoniae Pneumonia in Children

Status
Completed
Phase
Study type
Observational
Enrollment
964 (actual)
Sponsor
Beijing Friendship Hospital · Academic / Other
Sex
All
Age
1 Month – 14 Years
Healthy volunteers
Not accepted

Summary

Pneumonia is a major threat to the health of children. Mycoplasma pneumoniae infection is a core cause of pediatric pneumonia, and the incidence of severe mycoplasma pneumoniae pneumonia (SMPP) has increased in recent years. SMPP leads to a range of extrapulmonary symptoms, including myocardial and liver injury, which may be life-threatening. Therefore, there is an urgent need to establish an early warning model for SMPP to improve the prognosis of pediatric pneumonia. This observational study aims to establish a early prediction model of SMPP. Development cohorts are enrolled from Beijing Friendship Hospital between 2018-1-1 to 2024-5-31, and validation cohorts are enrolled between 2024-6-1 to 2025-6-30.

Conditions

Interventions

TypeNameDescription
OTHERmedical history taking, blood test, pulmonary ultrasoundmedical history taking, blood test, pulmonary ultrasound are used for MPP and SMPP diagnosis

Timeline

Start date
2018-01-01
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2026-01-12
Last updated
2026-01-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07333833. Inclusion in this directory is not an endorsement.

Development and Validation of an Early Prediction Model for Severe Mycoplasma Pneumoniae Pneumonia in Children (NCT07333833) · Clinical Trials Directory